Member of the Presidential Council of International Relations, President of the National Cultural Autonomy of Greeks in Russia, Coordinator of the World Council of Hellenes Abroad (SAE) of the countries of the Former Soviet Union, Founder and Chairman of the Board of Directors of «Agrocom Group» Holding Company, an outstanding philanthropist. BIOGRAPHY Ivan Savvidi, Greek by birth, was born on 27th of March 1959 in the Greek settlement of Georgian Soviet Socialist Republic, eighth child in a family of worker. After finishing secondary school in the Rostov region, he went to serve in Soviet Army, and quit the army in the rank of sergeant major. In1980 he came to the Rostov Tobacco Factory. In 1988 Ivan Savvidi graduated from the logistic faculty of Rostov State University of Economics. In 1993 he was elected as a General Director of the Company «Donskoy Tabak». In 1998 Ivan Savvidi started his political path, and up to 2003 was Member of Legislative Assembly of the Rostov region. In December 2003 Ivan Savvidi was elected as the State Duma Member of 4th convocation. Since April 2004 he was the Vice-chairman of Budget and Taxation Committee. In April 2007 Ivan Savvidi was reelected in Russian Federation State Duma, where he was a Member of Committee of International Affairs and Coordinator of Interparliamentary Deputy Group by Relations with Parliament of Greek Republic, Vice-chairman of the Commission of Parliament Assembly Of Russia and Belorussia Union by External Politics, member of PACE. Since 2012 Ivan Savvidi holds the position of the Chairman of the Board of Directors of the «Agrocom Group» Holding Company, founded in 2004. Ivan Savvidi is engaged in social activities, holds the position of the president of the National Cultural Autonomy of Russian Greeks, Coordinator of the World Council of Hellenes Abroad (SAE) of the countries of the Former Soviet Union. Since 2012 he is a Member of the Presidential Council of International Relations. In 2013 he was awarded the status of the Honourable citizen of Greece for his special role and contribution into development of relations between Russia and Greece, merits to Greek nation, Greek republic, world Orthodoxy, public and philanthropic activities. Ivan Savvidi adheres to the socially conscious position, he is a founder of Charitable Foundation that launches programs aimed at spiritual revival and restoration of Orthodox shrines, creative development of youth, promotion of healthy lifestyle, cultural, educational, scientific and research projects. Annual volume of charitable payments makes more than 2, 5 million EURO. Ivan Savvidi's achievements in public, social and economic activities and his contribution to social and economic development of Russia were honored by several national awards such as Medal of the Order of Merit for the Motherland, Medal of Honor, awards of Russian Orthodox Church, Presidential letters of gratitude etc. Ivan Savvidi is a candidate of economic science, has several works on logistic and marketing. Married, has two sons.
George D. Yancopoulos, M.D. Ph. D.
President of Regeneron Laboratories & Chief Scientific Officer Regeneron Pharmaceuticals Tarrytown, NY Dr. Yancopoulos graduated as valedictorian of both the Bronx High School of Science and Columbia College, and then earned his MD & PhD degrees at Columbia University’s College of Physicians and Surgeons. Dr. Yancopoulos left academia in 1989 to become scientific founder of Regeneron Pharmaceuticals, where he is President of Regeneron Laboratories and Chief Scientific Officer. Dr. Yancopoulos is a rare individual who has not only built one of the world’s “top ten” biotech companies from the ground up (working together with his long-time friend and partner, Dr. Len Schleifer, who is CEO of Regeneron), but simultaneously been recognized as a world-class basic science researcher, while also inventing some of the most valuable technologies and FDA-approved drugs in the industry. Dr. Yancopoulos has authored more than 350 scientific manuscripts, and, according to a study by the Institute for Scientific Information, was the eleventh most highly cited scientist in the world during the 1990’s. In 2004, he was elected to both the National Academy of Sciences and the American Academy of Sciences. Working with his team at Regeneron, Dr. Yancopoulos holds almost 100 patents, including for Regeneron’s foundational platforms for target and drug discovery such as Trap Technology, VelociGene® (which was utilized by the NIH for its $50M “Knock-Out the Mouse Genome Project”) and VelocImmuneTM (which is arguably one of the most valuable biotechnologies ever invented, having already generated more than $2.5B in licensing and collaboration revenues). Dr. Yancopoulos is also a principal inventor and developer of Regeneron’s three FDA-approved drugs, including EYLEA® (VEGF Trap-Eye, a new treatment for age-related macular degeneration), ZALTRAP® (VEGF Trap-Onc, for colorectal cancer), and ARCALYST® (the IL1-Trap, for orphan inflammatory disease). EYLEA® has already achieved blockbuster status, with one of the largest first-full year launches in biotech history. Dr. Yancopoulos’ team has recently progressed several fully human monoclonal antibodies (derived using his VelocImmuneTM platform) into advanced human trials for various indications, including cholesterol-lowering, rheumatoid arthritis, allergic asthma and atopic dermatitis.